Literature DB >> 16728285

Accurate diagnosis of acute graft-versus-host disease using serum proteomic pattern analysis.

Ramaprasad Srinivasan1, Jasmine Daniels, Vincent Fusaro, Andreas Lundqvist, Jonathan K Killian, David Geho, Martha Quezado, David Kleiner, Sally Rucker, Virginia Espina, Gordon Whiteley, Lance Liotta, Emmanuel Petricoin, Stefania Pittaluga, Ben Hitt, A J Barrett, Kevin Rosenblatt, Richard W Childs.   

Abstract

OBJECTIVE: The rapid diagnosis of acute graft-versus-host disease (GVHD) following allogeneic hematopoietic cell transplantation (HCT) is important for optimizing the management of this life-threatening complication. Current diagnostic techniques are time-consuming and require invasive tissue sampling. We investigated serum protein pattern analysis using surface-enhanced laser desorption ionization time-of-flight (SELDI-TOF) mass spectrometry as a tool to diagnose GVHD. PATIENTS AND METHODS: Eighty-eight serum samples were obtained from 34 patients undergoing HCT either pretransplant (n = 28 samples) or at various time points posttransplant (n = 60 samples), including 22 samples obtained on the day of onset of acute GVHD symptoms. Serum proteomic spectra generated from a "training set" of known samples were used to identify distinct proteomic patterns that best categorized a sample as either pretransplant, posttransplant non-GVHD, or GVHD; these distinct proteomic signatures were subsequently used to classify samples from a masked "test" sample set into the appropriate diagnostic category.
RESULTS: Proteomic pattern analysis accurately distinguished GVHD samples from both posttransplant non-GVHD samples and pretransplant samples (100% specificity and 100% sensitivity in both cases). Furthermore, distinct serum proteomic signatures were identified that distinguished pretransplant from posttransplant non-GVHD samples (100% specificity and 94% sensitivity).
CONCLUSION: These preliminary data suggest a potential application of SELDI-TOF-based proteomic analysis as a rapid and accurate method to diagnose acute GVHD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16728285     DOI: 10.1016/j.exphem.2006.02.013

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  19 in total

1.  Changes in salivary proteome following allogeneic hematopoietic stem cell transplantation.

Authors:  Matin M Imanguli; Jane C Atkinson; Kristen E Harvey; Gerard T Hoehn; Ok Hee Ryu; Tianxia Wu; Albert Kingman; A John Barrett; Michael R Bishop; Richard W Childs; Daniel H Fowler; Steven Z Pavletic; Thomas C Hart
Journal:  Exp Hematol       Date:  2007-02       Impact factor: 3.084

Review 2.  Discovery and validation of graft-versus-host disease biomarkers.

Authors:  Sophie Paczesny
Journal:  Blood       Date:  2012-11-19       Impact factor: 22.113

3.  Elafin is a biomarker of graft-versus-host disease of the skin.

Authors:  Sophie Paczesny; Thomas M Braun; John E Levine; Jason Hogan; Jeffrey Crawford; Bryan Coffing; Stephen Olsen; Sung W Choi; Hong Wang; Vitor Faca; Sharon Pitteri; Qing Zhang; Alice Chin; Carrie Kitko; Shin Mineishi; Gregory Yanik; Edward Peres; David Hanauer; Ying Wang; Pavan Reddy; Samir Hanash; James L M Ferrara
Journal:  Sci Transl Med       Date:  2010-01-06       Impact factor: 17.956

Review 4.  Graft-versus-host disease biomarkers: omics and personalized medicine.

Authors:  Sophie Paczesny; Nisha Raiker; Sam Brooks; Christy Mumaw
Journal:  Int J Hematol       Date:  2013-09       Impact factor: 2.490

5.  Decreased serum albumin as a biomarker for severe acute graft-versus-host disease after reduced-intensity allogeneic hematopoietic cell transplantation.

Authors:  Andrew R Rezvani; Barry E Storer; Rainer F Storb; Marco Mielcarek; David G Maloney; Brenda M Sandmaier; Paul J Martin; George B McDonald
Journal:  Biol Blood Marrow Transplant       Date:  2011-07-30       Impact factor: 5.742

6.  Plasma microRNA signature as a noninvasive biomarker for acute graft-versus-host disease.

Authors:  Bin Xiao; Yu Wang; Wei Li; Megan Baker; Jian Guo; Kelly Corbet; Ephraim L Tsalik; Qi-Jing Li; Scott M Palmer; Christopher W Woods; Zhiguo Li; Nelson J Chao; You-Wen He
Journal:  Blood       Date:  2013-09-16       Impact factor: 22.113

Review 7.  Plasma biomarkers in graft-versus-host disease: a new era?

Authors:  Sophie Paczesny; John E Levine; Thomas M Braun; James L M Ferrara
Journal:  Biol Blood Marrow Transplant       Date:  2009-01       Impact factor: 5.742

8.  Serum proteomic profiling and haptoglobin polymorphisms in patients with GVHD after allogeneic hematopoietic cell transplantation.

Authors:  Joseph McGuirk; Gang Hao; Weijian Hou; Sunil Abhyankar; Casey Williams; Weisi Yan; Jianda Yuan; Xiuqin Guan; Robert Belt; Shaun Dejarnette; Jeffery Wieman; Ying Yan
Journal:  J Hematol Oncol       Date:  2009-04-20       Impact factor: 17.388

9.  Examining the significance of fingerprint-based classifiers.

Authors:  Brian T Luke; Jack R Collins
Journal:  BMC Bioinformatics       Date:  2008-12-17       Impact factor: 3.169

10.  MicroRNA-181a, a potential diagnosis marker, alleviates acute graft versus host disease by regulating IFN-γ production.

Authors:  Wei Sang; Cong Zhang; Dianzheng Zhang; Ying Wang; Cai Sun; Mingshan Niu; Xiaoshen Sun; Cui Zhou; Lingyu Zeng; Bin Pan; Wei Chen; Dongmei Yan; Feng Zhu; Qingyun Wu; Jiang Cao; Kai Zhao; Chong Chen; Zhenyu Li; Depeng Li; Thomas P Loughran; Kailin Xu
Journal:  Am J Hematol       Date:  2015-10-08       Impact factor: 10.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.